Matthew Cavender
15PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 22, 2025
Public Reporting and Risk Aversion: Robust Risk Adjustment Is the Cure.Rajiv C Patel, David M Shahian, Matthew A Cavender
|Mar 31, 2025
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh
|Dec 12, 2023
Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis.Ofer Kobo, Matthew A Cavender, Thomas Jon Jensen
|Nov 29, 2023
Deferring PCI Based on IVUS Assessment: On Par With FFR or FLAVOUR of the Week?Max W Maffey, Matthew A Cavender, Rodrigo Bagur
|Apr 13, 2023
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.Su-Yen Goh, Mikhail N Kosiborod, Carolyn S P Lam
Pageof 3
Frequent Collaborators
2 joint publications
Eric Wittbrodt
2 joint publications
Carolyn S P Lam
2 joint publications
Deepak L Bhatt
1 joint publications
Colin P O'Leary
1 joint publications
Karolina Andersson Sundell
1 joint publications
Liyan Dong
1 joint publications
Phillip Hunt
1 joint publications
Nathan D Wong
1 joint publications
Cheli Melzer-Cohen
1 joint publications
Gregg W Stone